of Company Secretary, the Establishment of New Subsidiary and Subsidiary to Purchase Drug Care Company Limited (Revise no. 2) 10/11/2021 09:27 Notification of the resignation of Chairman of the Audit

Committee, Appointment of Audit Committee, Appointment of Company Secretary, the Establishment of New Subsidiary and Subsidiary to Purchase Drug Care Company Limited (Revise no. 2) 10/11/2021 09:27

the issuer’s core business. In any event, the issuer must not operate business in such a way that involves severely illegal business. For example, human trafficking, drug production or smuggling, or

additional investment to upgrade office building’s facilities. - Administration expenses increased due to additional headcount required for the succession plan. Extraordinary items included 15.2 million baht

involves severely illegal business. For example, human trafficking, drug smuggling or money laundering etc. Moreover, the issuer must not act in violation or non-compliance with the law, which may cause

first major period of generational succession. • Succession versus professionalization. - Surveys suggest preference amongst Asian family-firms for succession but growing recognition of need for

) EY 4 EY EY AQI 3 EY (3:1) 6:1) EY senior manager manager EY staff turnover 27.33%) (20.31%) EY EY career path) succession plan) EY 3.5 (Engagement Performance) EY engagement partner ) EY 2 engagement

firms in Asia include, in particular, leadership succession and corruption or family conflicts. Some research on family-controlled firms was cited illustrating the significant shareholder value that

system of new medicines according to the additional standards SET forth by the Food and Drug administration. Therefore, it is necessary to use the capital to proceed the project amount 32,000,000 baht

recognition Drug license Manufacturing service (OEM) Contracts with a customer ▪ บรษัิทยาท าสญัญาขายทะเบยีนต ารับยาทีไ่ดข้ ึน้ ทะเบยีนยากบั อย. แลว้ ใหล้กูคา้ ▪ ลกูคา้ยังไมไ่ดรั้บโอน ทะเบยีนต ารับยาตาม กฎหมาย